Mindful measures: Breakthrough dementia test offers early warning signs!
- Replies 1
In the realm of medical advancements, researchers have made significant strides in dementia detection, unveiling a promising new test that could revolutionise early diagnosis.
This breakthrough comes at a critical time, offering hope for identifying the disease years before symptoms manifest.
With dementia prevalence on the rise globally, the development of such a test holds immense potential to improve patient outcomes and enhance our understanding of this debilitating condition.
In a groundbreaking stride towards preemptive healthcare, scientists have developed a pioneering test that could signal the onset of dementia nine years before symptoms manifest.
This innovative approach, boasting an impressive 80 per cent accuracy rate, could dramatically alter how we anticipate and treat one of the most challenging conditions affecting our senior population.
A team of researchers from Queen Mary University of London honed in on a method that utilises brain scans during the brain's ‘idle mode’—a state where the mind is not actively engaged in a specific task.
This is a significant departure from traditional diagnostic tools, which often rely on memory tests or gauging brain shrinkage, and it could potentially bridge a vast clinical void by pinpointing individuals at risk of dementia.
They noted that this method has the ‘potential to fill an enormous clinical gap’ by identifying individuals susceptible to dementia and providing treatment prior to the manifestation of symptoms.
The study, which delved into the brain scans of over 1,100 participants from the UK Biobank, revealed that among the 103 individuals who eventually developed dementia, 81 had undergone brain scans that showed less connectivity during idle mode, from 5 months up to 8.5 years prior to their official diagnosis.
Their brain scans revealed reduced connectivity during rest periods compared to those who did not later develop dementia, according to the findings.
Professor Charles Marshall, who spearheaded the research, stated, ‘Predicting who is going to get dementia in the future will be vital for developing treatments that can prevent the irreversible loss of brain cells that causes the symptoms of dementia.’
‘Although we are getting better at detecting the proteins in the brain that can cause Alzheimer's disease, many people live for decades with these proteins in their brain without developing symptoms of dementia.’
‘We hope that the measure of brain function that we have developed will allow us to be much more precise about whether someone is actually going to develop dementia, and how soon, so that we can identify whether they might benefit from future treatments,’ he added.
Published in the journal Nature Mental Health, these findings have stirred the scientific community, with experts like Professor Andrew Doig of the University of Manchester suggesting that a predictive test for Alzheimer's could be just a ‘few years’ away.
‘Dementia is a complex condition, and it is unlikely that we will ever find one simple test that can accurately diagnose it,’ he remarked.
‘Within a few years, however, there is good reason to believe that we will be routinely testing for dementia in middle-aged people, using a combination of methods, such as a blood test, followed by imaging.’
‘The MRI connectivity method described here could form part of this diagnostic platform. We will then have an excellent understanding of which people are likely to benefit most from the new generation of dementia drugs,’ Professor Doig added.
However, Dr Richard Oakley, Associate Director of Research and Innovation at the Alzheimer's Society remarked that although the research successfully detected structural brain alterations prior to the onset of dementia symptoms, additional studies ‘involving diverse groups of people of different ages and ethnicities to fully understand the benefits and limitations of this MRI scan as a diagnostic tool’.
Professor Tara Spires-Jones, FMedSci, President of the British Neuroscience Association and professor at the UK Dementia Research Institute at the University of Edinburgh, also advised caution.
She mentioned that although this category of brain scan is valuable, it is ‘not widely available nor are they perfect at predicting who will go on to develop dementia’.
As scientists made strides in early dementia detection, the importance of proactive measures in preventing or managing the disease has become increasingly evident.
While the development of a test capable of identifying dementia nearly a decade before symptoms manifest is a significant breakthrough, understanding the lifestyle factors and warning signs associated with dementia is equally crucial.
A doctor's guide to dementia prevention offered valuable insights into lifestyle adjustments and warning signs to watch out for, empowering individuals to take proactive steps to safeguard their cognitive health.
How do you feel about the possibility of predicting dementia years before its onset? Do you believe this could change how we approach aging and brain health? Join the conversation below and let us know your perspective in the comments below.
This breakthrough comes at a critical time, offering hope for identifying the disease years before symptoms manifest.
With dementia prevalence on the rise globally, the development of such a test holds immense potential to improve patient outcomes and enhance our understanding of this debilitating condition.
In a groundbreaking stride towards preemptive healthcare, scientists have developed a pioneering test that could signal the onset of dementia nine years before symptoms manifest.
This innovative approach, boasting an impressive 80 per cent accuracy rate, could dramatically alter how we anticipate and treat one of the most challenging conditions affecting our senior population.
Researchers from Queen Mary University of London devised a groundbreaking test capable of predicting dementia up to nine years before diagnosis with 80 per cent accuracy. Credits: Shutterstock
A team of researchers from Queen Mary University of London honed in on a method that utilises brain scans during the brain's ‘idle mode’—a state where the mind is not actively engaged in a specific task.
This is a significant departure from traditional diagnostic tools, which often rely on memory tests or gauging brain shrinkage, and it could potentially bridge a vast clinical void by pinpointing individuals at risk of dementia.
They noted that this method has the ‘potential to fill an enormous clinical gap’ by identifying individuals susceptible to dementia and providing treatment prior to the manifestation of symptoms.
The study, which delved into the brain scans of over 1,100 participants from the UK Biobank, revealed that among the 103 individuals who eventually developed dementia, 81 had undergone brain scans that showed less connectivity during idle mode, from 5 months up to 8.5 years prior to their official diagnosis.
Their brain scans revealed reduced connectivity during rest periods compared to those who did not later develop dementia, according to the findings.
Professor Charles Marshall, who spearheaded the research, stated, ‘Predicting who is going to get dementia in the future will be vital for developing treatments that can prevent the irreversible loss of brain cells that causes the symptoms of dementia.’
‘Although we are getting better at detecting the proteins in the brain that can cause Alzheimer's disease, many people live for decades with these proteins in their brain without developing symptoms of dementia.’
‘We hope that the measure of brain function that we have developed will allow us to be much more precise about whether someone is actually going to develop dementia, and how soon, so that we can identify whether they might benefit from future treatments,’ he added.
Published in the journal Nature Mental Health, these findings have stirred the scientific community, with experts like Professor Andrew Doig of the University of Manchester suggesting that a predictive test for Alzheimer's could be just a ‘few years’ away.
‘Dementia is a complex condition, and it is unlikely that we will ever find one simple test that can accurately diagnose it,’ he remarked.
‘Within a few years, however, there is good reason to believe that we will be routinely testing for dementia in middle-aged people, using a combination of methods, such as a blood test, followed by imaging.’
‘The MRI connectivity method described here could form part of this diagnostic platform. We will then have an excellent understanding of which people are likely to benefit most from the new generation of dementia drugs,’ Professor Doig added.
However, Dr Richard Oakley, Associate Director of Research and Innovation at the Alzheimer's Society remarked that although the research successfully detected structural brain alterations prior to the onset of dementia symptoms, additional studies ‘involving diverse groups of people of different ages and ethnicities to fully understand the benefits and limitations of this MRI scan as a diagnostic tool’.
Professor Tara Spires-Jones, FMedSci, President of the British Neuroscience Association and professor at the UK Dementia Research Institute at the University of Edinburgh, also advised caution.
She mentioned that although this category of brain scan is valuable, it is ‘not widely available nor are they perfect at predicting who will go on to develop dementia’.
As scientists made strides in early dementia detection, the importance of proactive measures in preventing or managing the disease has become increasingly evident.
While the development of a test capable of identifying dementia nearly a decade before symptoms manifest is a significant breakthrough, understanding the lifestyle factors and warning signs associated with dementia is equally crucial.
A doctor's guide to dementia prevention offered valuable insights into lifestyle adjustments and warning signs to watch out for, empowering individuals to take proactive steps to safeguard their cognitive health.
.png){kind=icon}
